Phase I Study in Advanced Solid Tumors

Summary

Dose escalating study of orally administered indibulin at twice daily schedule in subjects with solid tumors.

Timeline

Start

2007-06

Primary completion

2013-06

Completion

2013-06

Publications

• Kapoor S, Srivastava S, Panda D. Indibulin dampens microtubule dynamics and produces synergistic antiproliferative effect with vinblastine in MCF-7 cells: Implications in cancer chemotherapy. Sci Rep. 2018 Aug 17;8(1):12363. doi: 10.1038/s41598-018-30376-y.

Drugs

Indications